Tristel plc (AIM: TSTL)
London
· Delayed Price · Currency is GBP · Price in GBX 399.00
-5.00 (-1.24%)
Jan 21, 2025, 4:05 PM GMT+1
Tristel Revenue
In the fiscal year ending June 30, 2024, Tristel had annual revenue of 41.93M GBP with 16.45% growth. Tristel had revenue of 20.99M in the half year ending June 30, 2024, with 31.20% growth.
Revenue
41.93M
Revenue Growth
+16.45%
P/S Ratio
4.47
Revenue / Employee
179.97K
Employees
233
Market Cap
188.38M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 41.93M | 5.92M | 16.45% |
| Jun 30, 2023 | 36.01M | 4.89M | 15.70% |
| Jun 30, 2022 | 31.12M | 125.00K | 0.40% |
| Jun 30, 2021 | 31.00M | -680.00K | -2.15% |
| Jun 30, 2020 | 31.68M | 5.51M | 21.05% |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
| Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 38.20B |
| GSK plc | 31.31B |
| Haleon | 11.24B |
| Smith & Nephew | 4.46B |
| ConvaTec Group | 1.74B |
| Hikma Pharmaceuticals | 2.39B |
| HUTCHMED (China) | 483.31M |
| Oxford Nanopore Technologies | 167.75M |
Tristel News
- 3 months ago - Full Year 2024 Tristel PLC Analyst briefing Transcript - GuruFocus